[1]CurrentPatentAssignee:INCYTECORP-US2011/224190,2011,A1Locationinpatent:Page/Pagecolumn121
[1]JournalofMedicinalChemistry,2014,vol.57,p.5935-5948
115627-41-3 | N-(3-Indolylformyl)-l-phenylalanine | AA000G7E | MFCD08061355
1153002-90-4 | 6-Bromo-4-chloro-2,8-dimethylquinoline | AA000GI4 | MFCD12114952
1158750-91-4 | tert-Butyl 3-oxo-2,7-diazaspiro[4.5]decane-7-carboxylate | AA000GX8 | MFCD00005794
115956-13-3 | Dalasetron Mesylate | AA000H54 | MFCD01718979
116-25-6 | 1-Hydroxymethyl-5,5-dimethylhydantoin | AA000HCO | MFCD00020866
119061-16-4 | 2-(4-Chlorophenoxy)pentanoic acid | AA000I1S | MFCD02295839
119223-01-7 | 5-(Chloromethyl)-3-cyclopropyl-1,2,4-oxadiazole | AA000IC0 | MFCD09816101
1194-86-1 | (R)-3-Thienylglycine | AA000IMN | MFCD00079614
119584-72-4 | 2-(Ethylamino)-6-fluorobenzonitrile | AA000IWZ | MFCD12193244
1227581-80-7 | 2-Nitro-6-(trifluoromethyl)benzonitrile | AA000JA3 | MFCD16606330